BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33890306)

  • 1. Clinical analysis of Pseudomonas aeruginosa-positive and -negative green nail syndrome cases: A single center retrospective analysis.
    Lee H; Mun JH; Cho S; Park H
    J Dermatol; 2021 Jul; 48(7):1073-1076. PubMed ID: 33890306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloronychia: green nail syndrome caused by Pseudomonas aeruginosa in elderly persons.
    Chiriac A; Brzezinski P; Foia L; Marincu I
    Clin Interv Aging; 2015; 10():265-7. PubMed ID: 25609938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective Case Series on Risk Factors, Diagnosis and Treatment of Pseudomonas aeruginosa Nail Infections.
    Geizhals S; Lipner SR
    Am J Clin Dermatol; 2020 Apr; 21(2):297-302. PubMed ID: 31595433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green Nail Syndrome Treated with Ozenoxacin: Two Case Reports.
    Cosio T; Petruccelli R; Gaziano R; Fontana C; Favaro M; Zampini P; Pistoia ES; Diluvio L; Lozzi F; Bianchi L; Campione E
    Case Rep Dermatol; 2023; 15(1):217-224. PubMed ID: 38023344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green Nail Syndrome (Pseudomonas aeruginosa Nail Infection): Two Cases Successfully Treated with Topical Nadifloxacin, an Acne Medication.
    Müller S; Ebnöther M; Itin P
    Case Rep Dermatol; 2014 May; 6(2):180-4. PubMed ID: 25202260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Green Nail Syndrome Diagnosed in the Emergency Department.
    Carhart P; Espinosa J; Lucerna A
    Cureus; 2024 Mar; 16(3):e57032. PubMed ID: 38681312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Green nail syndrome or chloronychia].
    Maes M; Richert B; de la Brassinne M
    Rev Med Liege; 2002 Apr; 57(4):233-5. PubMed ID: 12073797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report: Novel use of the conventional method- chemical nail avulsion may be effective for treatment of green nail syndrome.
    Yu Q; Wang Y; Yang H; Li W; Yang L
    Front Med (Lausanne); 2022; 9():991918. PubMed ID: 36091683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green nail: Etiology and treatment of chloronychia.
    Baran R; Richert B
    Hand Surg Rehabil; 2024 Apr; 43S():101653. PubMed ID: 38879229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green nail syndrome complicated by pseudomonal keratitis in a teenager with artificial nails.
    Nowakowska MK; Rodriguez ED; Gurney NT; Chang JY; Hunt RD; Yen KG; Kim EJ; Metry DW
    Pediatr Dermatol; 2023 Jan; 40(1):216-218. PubMed ID: 36002400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE ROLE OF PSEUDOMONAS AERUGINOSA IN NAIL DISEASE.
    STONE OJ; MULLINS JF
    J Invest Dermatol; 1963 Jul; 41():25-6. PubMed ID: 14043007
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes of hospitalized neutropenic oncology patients with Pseudomonas aeruginosa bloodstream infections: focus on oral fluoroquinolone conversion.
    Yan LZ; Herrington JD
    J Oncol Pharm Pract; 2016 Aug; 22(4):584-90. PubMed ID: 26156260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitis.
    Guss J; Abuzeid WM; Doghramji L; Edelstein PH; Chiu AG
    ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):263-7. PubMed ID: 19797934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green nail syndrome treated with the application of tobramycin eye drop.
    Bae Y; Lee GM; Sim JH; Lee S; Lee SY; Park YL
    Ann Dermatol; 2014 Aug; 26(4):514-6. PubMed ID: 25143684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals.
    Eagye KJ; Nicolau DP
    Adv Ther; 2011 Apr; 28(4):326-33. PubMed ID: 21445549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: Green nail syndrome in an epidemic prevention volunteer during the outbreak of the Omicron in Shanghai.
    Yu Q; Hu S; Li W; Yang L
    Front Public Health; 2022; 10():1009517. PubMed ID: 36203662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
    Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
    Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.
    Paladino JA; Sunderlin JL; Forrest A; Schentag JJ
    J Antimicrob Chemother; 2003 Sep; 52(3):457-63. PubMed ID: 12888598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa folliculitis after shower/bath exposure.
    Zichichi L; Asta G; Noto G
    Int J Dermatol; 2000 Apr; 39(4):270-3. PubMed ID: 10809975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.